B
22.89
0.12 (0.53%)
| Previous Close | 22.77 |
| Open | 23.04 |
| Volume | 2,121,353 |
| Avg. Volume (3M) | 2,278,124 |
| Market Cap | 4,024,153,344 |
| Price / Earnings (TTM) | 84.78 |
| Price / Earnings (Forward) | 38.17 |
| Price / Sales | 0.380 |
| Price / Book | 2.30 |
| 52 Weeks Range | |
| Earnings Date | 31 Jul 2025 - 4 Aug 2025 |
| Profit Margin | 0.48% |
| Operating Margin (TTM) | 1.77% |
| Diluted EPS (TTM) | 0.270 |
| Quarterly Revenue Growth (YOY) | 25.90% |
| Quarterly Earnings Growth (YOY) | 399.50% |
| Total Debt/Equity (MRQ) | 160.76% |
| Current Ratio (MRQ) | 1.74 |
| Operating Cash Flow (TTM) | 204.23 M |
| Levered Free Cash Flow (TTM) | -385.76 M |
| Return on Assets (TTM) | 4.39% |
| Return on Equity (TTM) | 2.74% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Mixed | |
| Stock | BrightSpring Health Services, I | Bearish | Bullish |
AIStockmoo Score
-0.3
| Analyst Consensus | 1.0 |
| Insider Activity | -1.5 |
| Price Volatility | -0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.30 |
|
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Service. and others. It generates the majority of its revenue from the Pharmacy Solutions segment. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 3.29% |
| % Held by Institutions | 96.21% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Walgreens Boots Alliance, Inc. | 31 Mar 2025 | 11,239,996 |
| Sea Cliff Partners Management, Lp | 31 Mar 2025 | 2,033,247 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 27.00 (Wells Fargo, 17.96%) | Buy |
| Median | 26.00 (13.59%) | |
| Low | 25.00 (Morgan Stanley, 9.22%) | Buy |
| Average | 26.00 (13.59%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 23.03 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Wells Fargo | 13 May 2025 | 27.00 (17.96%) | Buy | 23.24 |
| Morgan Stanley | 09 May 2025 | 25.00 (9.22%) | Buy | 22.82 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 08 Jul 2025 | Announcement | BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025 |
| 18 Jun 2025 | Announcement | BrightSpring Health Services Announces Onco360® Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs |
| 10 Jun 2025 | Announcement | BrightSpring Announces Secondary Offering of Common Stock |
| 02 May 2025 | Announcement | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |